Targeting CD19-Negative Relapsed B-Acute Lymphoblastic Leukemia Using Trivalent CAR T Cells

被引：0

作者：

Fousek, Kristen ^{[1
]}

Watanabe, Junji ^{[2
]}

George, Ann ^{[2
]}

Byrd, Tiara ^{[1
]}

An, Xingyue ^{[3
]}

Samaha, Hebatalla ^{[1
]}

Salsman, Vita ^{[1
]}

Navai, Shoba ^{[1
]}

Jang, Albert ^{[1
]}

Kim, Hye Na ^{[2
]}

Joseph, Sujith ^{[1
]}

Baker, Matthew ^{[1
]}

Varadarajan, Navin ^{[3
]}

Hegde, Meenakshi ^{[1
]}

Kim, Yong-Mi ^{[2
]}

Heisterkamp, Nora ^{[2
]}

Abdel-Azim, Hisham ^{[2
]}

Ahmed, Nabil ^{[1
]}

机构：

[1] Baylor Coll Med, Houston, TX 77030 USA

[2] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA

[3] Univ Houston, Houston, TX USA

来源：

MOLECULAR THERAPY | 2018年 / 26卷 / 05期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

647

引用

页码：298 / 298

页数：1

共 50 条

[21] CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial
Cordoba, Shaun
Onuoha, Shimobi
Thomas, Simon
Pignataro, Daniela Soriano
Hough, Rachael
Ghorashian, Sara
Vora, Ajay
Bonney, Denise
Veys, Paul
Rao, Kanchan
Lucchini, Giovanna
Chiesa, Robert
Chu, Jan
Clark, Liz
Fung, Mei Mei
Smith, Koval
Peticone, Carlotta
Al-Hajj, Muhammad
Baldan, Vania
Ferrari, Mathieu
Srivastava, Saket
Jha, Ram
Vargas, Frederick Arce
Duffy, Kevin
Day, William
Virgo, Paul
Wheeler, Lucy
Hancock, Jeremy
Farzaneh, Farzin
Domning, Sabine
Zhang, Yiyun
Khokhar, Nushmia Z.
Peddareddigari, Vijay G. R.
Wynn, Robert
Pule, Martin
Amrolia, Persis J.
NATURE MEDICINE, 2021, 27 (10) : 1797 - +
[22] A Clinical Trial Using Third Generation CD19 Targeting CAR T Cells for Relapsed Lymphoma and Leukemia
Enblad, Gunilla
Karlsson, Hannah
Wenthe, Jessica
Wikstrom, Kristina I.
Essand, Magnus
Savoldo, Barbara
Dotti, Gianpietro
Hoglund, Martin
Hallbook, Helene
Brenner, Malcolm K.
Hagberg, Hans
Loskog, Angelica
MOLECULAR THERAPY, 2016, 24 : S295 - S296
[23] CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial
Shaun Cordoba
Shimobi Onuoha
Simon Thomas
Daniela Soriano Pignataro
Rachael Hough
Sara Ghorashian
Ajay Vora
Denise Bonney
Paul Veys
Kanchan Rao
Giovanna Lucchini
Robert Chiesa
Jan Chu
Liz Clark
Mei Mei Fung
Koval Smith
Carlotta Peticone
Muhammad Al-Hajj
Vania Baldan
Mathieu Ferrari
Saket Srivastava
Ram Jha
Frederick Arce Vargas
Kevin Duffy
William Day
Paul Virgo
Lucy Wheeler
Jeremy Hancock
Farzin Farzaneh
Sabine Domning
Yiyun Zhang
Nushmia Z. Khokhar
Vijay G. R. Peddareddigari
Robert Wynn
Martin Pule
Persis J. Amrolia
Nature Medicine, 2021, 27 : 1797 - 1805
[24] CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
Jing Pan
Qing Niu
Biping Deng
Shuangyou Liu
Tong Wu
Zhiyong Gao
Zhaoli Liu
Yue Zhang
Xiaomin Qu
Yanlei Zhang
Shaohui Liu
Zhuojun Ling
Yuehui Lin
Yongqiang Zhao
Yanzhi Song
Xiyou Tan
Yan Zhang
Zhihui Li
Zhichao Yin
Bingzhen Chen
Xinjian Yu
Ju Yan
Qinlong Zheng
Xuan Zhou
Jin Gao
Alex H. Chang
Xiaoming Feng
Chunrong Tong
Leukemia, 2019, 33 : 2854 - 2866
[25] CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
Jing, P.
Niu, Q.
Deng, B.
Liu, S.
Wu, T.
Gao, Z.
Chang, A. H.
Feng, X.
Tong, C.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1723 - 1723
[26] CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
Pan, Jing
Niu, Qing
Deng, Biping
Liu, Shuangyou
Wu, Tong
Gao, Zhiyong
Liu, Zhaoli
Zhang, Yue
Qu, Xiaomin
Zhang, Yanlei
Liu, Shaohui
Ling, Zhuojun
Lin, Yuehui
Zhao, Yongqiang
Song, Yanzhi
Tan, Xiyou
Zhang, Yan
Li, Zhihui
Yin, Zhichao
Chen, Bingzhen
Yu, Xinjian
Yan, Ju
Zheng, Qinlong
Zhou, Xuan
Gao, Jin
Chang, Alex H.
Feng, Xiaoming
Tong, Chunrong
LEUKEMIA, 2019, 33 (12) : 2854 - 2866
[27] Sequential CD19 and CD22 CAR-T Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia
Yang, Tingting
Dong, Yetian
Zhang, Mingming
Feng, Jingjing
Fu, Shan
Xiao, Pingnan
Hong, Ruimin
Xu, Huijun
Cui, Jiazhen
Huang, Simao
Wei, Guoqing
Chang, Alex H.
Huang, He
Hu, Yongxian
BLOOD, 2024, 144 : 2819 - 2819
[28] Sequential therapy with inotuzumab ozogamicin, CD19 CAR T cells, and blinatumomab in an elderly patient with relapsed acute lymphoblastic leukemia
Ramona Wullenkord
Christian Reicherts
Jan-Henrik Mikesch
Julia Marx
Klaus Wethmar
Jörn Albring
Simon Call
Georg Lenz
Matthias Stelljes
Annals of Hematology, 2021, 100 : 587 - 589
[29] Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia
C Rossig
M Pule
B Altvater
S Saiagh
G Wright
S Ghorashian
L Clifton-Hadley
K Champion
Z Sattar
B Popova
A Hackshaw
P Smith
T Roberts
E Biagi
B Dreno
R Rousseau
S Kailayangiri
M Ahlmann
R Hough
B Kremens
M G Sauer
P Veys
N Goulden
M Cummins
P J Amrolia
Leukemia, 2017, 31 : 1087 - 1095
[30] Sequential therapy with inotuzumab ozogamicin, CD19 CAR T cells, and blinatumomab in an elderly patient with relapsed acute lymphoblastic leukemia
Wullenkord, Ramona
Reicherts, Christian
Mikesch, Jan-Henrik
Marx, Julia
Wethmar, Klaus
Albring, Joern
Call, Simon
Lenz, Georg
Stelljes, Matthias
ANNALS OF HEMATOLOGY, 2021, 100 (02) : 587 - 589

← 1 2 3 4 5 →